CS logo
small CS logo
Northwest Cancer Specialists, P.C.

Portland, Oregon, United States
Oncologist in Portland, Oregon
5050 NE Hoyt St # 256, Portland, OR 97213

About Northwest Cancer Specialists, P.C.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Novartis Pharmaceuticals
10
SWOG Cancer Research Network
10
Bristol-Myers Squibb
7
Pfizer
7
Alliance for Clinical Trials in Oncology
2
Celgene
2
Dendreon
2
GRAIL, LLC
2
Gilead Sciences
2
Hoffmann-La Roche
2
Janssen Research & Development, LLC
2
Total Rows: 43

Clinical Trials at Northwest Cancer Specialists, P.C.


During the past decade, Northwest Cancer Specialists, P.C. conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 41 clinical trials were completed, i.e. on average, 141.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 13 clinical trials were completed. i.e. 185.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years3333554477333311117711114455445522Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
2003-07-01
2010-12-01
Completed
46
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
2003-11-01
2027-01-01
Active, not recruiting
3,294
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
2005-05-01
2012-05-01
Terminated
22
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
2005-11-01
Completed
829
Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
2006-04-01
2008-12-01
Unknown status
60
Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.
2006-04-01
2009-01-01
Completed
76
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
2006-09-01
2014-06-01
Completed
1,252
Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
2006-11-01
2009-03-01
Completed
75

Rows per page:

1–88 of 88

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Northwest Cancer Specialists, P.C." #1 sponsor was "Novartis Pharmaceuticals" with 10 trials, followed by "SWOG Cancer Research Network" with 10 trials sponsored, "Bristol-Myers Squibb" with 7 trials sponsored, "Pfizer" with 7 trials sponsored and "Alliance for Clinical Trials in Oncology" with 7 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 43 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Cancer Specialists, P.C." #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 3 trials as a collaborator, "GOG Foundation" with 3 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 3 trials as a collaborator and "US Oncology Research" with 3 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 27 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNovartis Pharmaceuticals: 10Novartis Pharmaceuticals: 10SWOG Cancer ResearchNetwork: 10SWOG Cancer ResearchNetwork: 10Bristol-Myers Squibb: 7Bristol-Myers Squibb: 7Pfizer: 7Pfizer: 7Alliance for ClinicalTrials in Oncology: 2Alliance for ClinicalTrials in Oncology: 2Celgene: 2Celgene: 2Dendreon: 2Dendreon: 2GRAIL, LLC: 2GRAIL, LLC: 2Gilead Sciences: 2Gilead Sciences: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 16National CancerInstitute (NCI): 16European Network ofGynaecologicalOncological Trial Groups(ENGOT): 3European Network ofGynaecologicalOncological Trial Groups(ENGOT): 3GOG Foundation: 3GOG Foundation: 3Ono Pharmaceutical Co. Ltd: 3Ono Pharmaceutical Co. Ltd: 3US Oncology Research: 3US Oncology Research: 3Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Eastern CooperativeOncology Group: 2Eastern CooperativeOncology Group: 2Genentech, Inc.: 2Genentech, Inc.: 2NRG Oncology: 2NRG Oncology: 2Academic andCommunity CancerResearch United: 1Academic andCommunity CancerResearch United: 1

Clinical Trials Conditions at Northwest Cancer Specialists, P.C.


According to Clinical.Site data, the most researched conditions in "Northwest Cancer Specialists, P.C." are "Breast Cancer" (10 trials), "Metastatic Breast Cancer" (10 trials), "Ovarian Cancer" (6 trials), "Fallopian Tube Cancer" (5 trials) and "Advanced Breast Cancer" (4 trials). Many other conditions were trialed in "Northwest Cancer Specialists, P.C." in a lesser frequency.

Clinical Trials Intervention Types at Northwest Cancer Specialists, P.C.


Most popular intervention types in "Northwest Cancer Specialists, P.C." are "Drug" (77 trials), "Biological" (12 trials), "Other" (9 trials), "Radiation" (5 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Nivolumab" (7 trials), "Carboplatin" (6 trials), "Paclitaxel" (6 trials), "Placebo" (6 trials) and "cisplatin" (5 trials). Other intervention names were less common.

Clinical Trials Genders at Northwest Cancer Specialists, P.C.


The vast majority of trials in "Northwest Cancer Specialists, P.C." are 59 trials for "All" genders, 26 trials for "Female" genders and 3 trials for "Male" genders.

Clinical Trials Status at Northwest Cancer Specialists, P.C.


Currently, there are NaN active trials in "Northwest Cancer Specialists, P.C.". undefined are not yet recruiting, 8 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 54 completed trials in Northwest Cancer Specialists, P.C., undefined suspended trials, and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Northwest Cancer Specialists, P.C., 10 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 37Phase 2: 37Phase 3: 33Phase 3: 33Phase 1: 10Phase 1: 10Not Applicable: 2Not Applicable: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 54Completed: 54Active, not recruiting: 14Active, not recruiting: 14Terminated: 10Terminated: 10Recruiting: 8Recruiting: 8No longer available: 1No longer available: 1Unknown status: 1Unknown status: 1